Compare IMNM & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | GOODN |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | N/A |
| IPO Year | 2020 | 2003 |
| Metric | IMNM | GOODN |
|---|---|---|
| Price | $20.84 | $20.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 3.7K |
| Earning Date | 11-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $6,941,000.00 | ★ $161,336,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,534.68 | N/A |
| P/E Ratio | ★ N/A | $115.89 |
| Revenue Growth | N/A | ★ 8.00 |
| 52 Week Low | $11.55 | $20.80 |
| 52 Week High | $30.06 | $23.91 |
| Indicator | IMNM | GOODN |
|---|---|---|
| Relative Strength Index (RSI) | 32.99 | 23.99 |
| Support Level | $19.39 | N/A |
| Resistance Level | $23.25 | $22.67 |
| Average True Range (ATR) | 1.08 | 0.44 |
| MACD | -0.35 | -0.15 |
| Stochastic Oscillator | 11.87 | 10.55 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.